As we age, our brains face challenges like slower reaction times and memory lapses. But researchers reveal that exceptional cognitive performance is attainable through habits like quality sleep and cardiovascular health. Learn the secrets to maintaining a youthful brain!
A new study reveals alarming links between frequent gabapentin prescriptions for chronic low back pain and increased risks of dementia and mild cognitive impairment, especially in younger adults. Learn why monitoring is essential.
A groundbreaking study reveals that insulin resistance, measured by the triglyceride-glucose (TyG) index, can be a crucial indicator of rapid cognitive decline in Alzheimer's patients. Those with higher TyG levels face a fourfold increase in deterioration rates, prompting new intervention strategies.
A new MIT study suggests that using ChatGPT may lead to cognitive decline. Participants using the AI tool showed lower neural engagement and struggled with memory retention compared to those writing without assistance.
A new MIT study shows that ChatGPT users may be experiencing cognitive decline, with brain scans revealing concerning trends in neural activity compared to non-users. The research raises alarms about AI's impact on mental health and critical thinking.
A groundbreaking study reveals that following the MIND diet can significantly lower the risk of Alzheimer's and related dementias. Discover how adopting healthier eating habits can benefit brain health at any age!
A new study reveals that engaging with digital technology may significantly reduce the risk of cognitive impairment among middle-aged and older adults. Discover how smartphones and tablets might help preserve brain function!
In a bold statement, former Los Angeles Mayor Antonio Villaraigosa claims Kamala Harris and Xavier Becerra were complicit in a cover-up regarding President Biden's cognitive decline. This revelation raises questions about transparency and accountability in the upcoming California governor race.
The FDA has approved the first blood test for Alzheimer's, allowing for earlier diagnosis and treatment with existing drugs. This groundbreaking development could significantly impact millions facing cognitive decline.
The FDA has approved the first blood test for Alzheimer's, allowing for earlier treatment with existing drugs. This innovative test measures protein ratios linked to the disease, promising better patient outcomes.
